Detection of soluble amyloid-β oligomers and insoluble high-molecular-weight particles in CSF: Development of methods with potential for diagnosis and therapy monitoring of Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Funke, Susanne Aileen ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; MONOMER; OLIGOMER;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LASER MICROSCOPY; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SURFACE PLASMON RESONANCE;

EID: 84855286263     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/151645     Document Type: Review

References (55)

1. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer's disease Alzheimer's and Dementia 2007 3 3 186 191 (Pubitemid 46825511)
2. Haass C., Selkoe D. J., Cellular processing of -amyloid precursor protein and the genesis of amyloid -peptide Cell 1993 75 6 1039 1042
3. Kang J., Lemaire H. G., Unterbeck A., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 1987 325 6106 733 736 (Pubitemid 17054046)
4. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., Beyreuther K., Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein Cell 1989 57 1 115 126 (Pubitemid 19098873)
5. Selkoe D. J., The molecular pathology of Alzheimer's disease Neuron 1991 6 4 487 498
6. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185
7. Haass C., Selkoe D. J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide Nature Reviews Molecular Cell Biology 2007 8 2 101 112 (Pubitemid 46432529)
8. Shankar G. M., Bloodgood B. L., Townsend M., Walsh D. M., Selkoe D. J., Sabatini B. L., Natural oligomers of the Alzheimer amyloid- protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway Journal of Neuroscience 2007 27 11 2866 2875 (Pubitemid 46438992)
9. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nature Medicine 2008 14 8 837 842
10. Walsh D. M., Selkoe D. J., A oligomersa decade of discovery Journal of Neurochemistry 2007 101 5 1172 1184
11. Ganguli M., Rodriguez E., Mulsant B., Richards S., Pandav R., Bilt J. V., Dodge H. H., Stoehr G. P., Saxton J., Morycz R. K., Rubin R. T., Farkas B., DeKosky S. T., Detection and management of cognitive impairment in primary care: the steel valley seniors survey Journal of the American Geriatrics Society 2004 52 10 1668 1675 (Pubitemid 41709920)
12. Knopman D. S., DeKosky S. T., Cummings J. L., Chui H., Corey-Bloom J., Relkin N., Small G. W., Miller B., Stevens J. C., Practice parameter: diagnosis of dementia (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology Neurology 2001 56 9 1143 1153 (Pubitemid 32405708)
13. Visser P. J., Scheltens P., Verhey F. R., Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? Journal of Neurology, Neurosurgery and Psychiatry 2005 76 10 1348 1354 (Pubitemid 41360969)
14. Braak H., Braak E., Frequency of stages of Alzheimer-related lesions in different age categories Neurobiology of Aging 1997 18 4 351 357 (Pubitemid 27435070)
15. Mintun M. A., Larossa G. N., Sheline Y. I., Dence C. S., Lee S. Y., Mach R. H., Klunk W. E., Mathis C. A., Dekosky S. T., Morris J. C., [ 11 C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 2006 67 3 446 452 (Pubitemid 44214969)
16. Price J. L., McKeel D. W. Jr., Buckles V. D., Roe C. M., Xiong C., Grundman M., Hansen L. A., Petersen R. C., Parisi J. E., Dickson D. W., Smith C. D., Davis D. G., Schmitt F. A., Markesbery W. R., Kaye J., Kurlan R., Hulette C., Kurland B. F., Higdon R., Kukull W., Morris J. C., Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiology of Aging 2009 30 7 1026 1036
17. Dubois B., Feldman H. H., Jacova C., Cummings J. L., DeKosky S. T., Barberger-Gateau P., Delacourte A., Frisoni G., Fox N. C., Galasko D., Gauthier S., Hampel H., Jicha G. A., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Sarazin M., de Souza L. C., Stern Y., Visser P. J., Scheltens P., Revising the definition of Alzheimer's disease: a new lexicon The Lancet Neurology 2010 9 11 1118 1127
18. Dubois B., Feldman H. H., Jacova C., DeKosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria The Lancet Neurology 2007 6 8 734 746 (Pubitemid 47058377)
19. Golde T. E., Schneider L. S., Koo E. H., Anti-A therapeutics in Alzheimer's disease: the need for a paradigm shift Neuron 2011 69 2 203 213
20. Jakob Roland J., Jacobsen H., Alzheimer's disease: from pathology to therapeutic approaches Angewandte Chemie 2009 48 17 3030 3059
21. Nerelius C., Johansson J., Sandegren A., Amyloid beta-peptide aggregation. What does it result in and how can it be prevented? Frontiers in Bioscience 2009 14 1716 1729
22. Blennow K., Biomarkers in Alzheimer's disease drug development Nature Medicine 2010 16 11 1218 1222
23. Zetterberg H., Blennow K., Biological CSF markers of Alzheimer's disease Handbook of Clinical Neurology 2008 89 261 268
24. Blennow K., Hampel H., Weiner M., Zetterberg H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nature Reviews Neurology 2010 6 3 131 144
25. Prvulovic D., Hampel H., Amyloid (A ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease Clinical Chemistry and Laboratory Medicine 2011 49 3 367 374
26. Georganopoulou D. G., Chang L., Nam J. M., Thaxton C. S., Mufson E. J., Klein W. L., Mirkin C. A., Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2273 2276 (Pubitemid 40279365)
27. Haes A. J., Chang L., Klein W. L., Van Duyne R. P., Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor Journal of the American Chemical Society 2005 127 7 2264 2271 (Pubitemid 40270531)
28. Fukumoto H., Tokuda T., Kasai T., Ishigami N., Hidaka H., Kondo M., Allsop D., Nakagawa M., High-molecular-weight -amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients FASEB Journal 2010 24 8 2716 2726
29. Gao C. M., Yam A. Y., Wang X., Magdangal E., Salisbury C., Peretz D., Zuckermann R. N., Connolly M. D., Hansson O., Minthon L., Zetterberg H., Blennow K., Fedynyshyn J. P., Allauzen S., A 40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease PLoS One 2010 5 12
30. Finder V. H., Glockshuber R., Amyloid- aggregation Neurodegenerative Diseases 2007 4 1 13 27
31. Lesné S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., Ashe K. H., A specific amyloid- protein assembly in the brain impairs memory Nature 2006 440 7082 352 357
32. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D., Isolation and quantification of soluble Alzheimer's -peptide from biological fluids Nature 1992 359 6393 325 327
33. Fndrich M., Schmidt M., Grigorieff N., Recent progress in understanding Alzheimer's -amyloid structures Trends in Biochemical Sciences 2011 36 6 338 345
34. Habicht G., Haupt C., Friedrich R. P., Hortschansky P., Sachse C., Meinhardt J., Wieligmann K., Gellermann G. P., Brodhun M., Gtz J., Halbhuber K. J., Rcken C., Horn U., Fndrich M., Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing A protofibrils Proceedings of the National Academy of Sciences of the United States of America 2007 104 49 19232 19237
35. Hillen H., Barghorn S., Striebinger A., Labkovsky B., Mller R., Nimmrich V., Nolte M. W., Perez-Cruz C., Van Der Auwera I., Van Leuven F., Van Gaalen M., Bespalov A. Y., Schoemaker H., Sullivan J. P., Ebert U., Generation and therapeutic efficacy of highly oligomer-specific -amyloid antibodies Journal of Neuroscience 2010 30 31 10369 10379
36. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W., Glabel C. G., Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 2003 300 5618 486 489 (Pubitemid 36444329)
37. Lambert M. P., Viola K. L., Chromy B. A., Chang L., Morgan T. E., Yu J., Venton D. L., Krafft G. A., Finch C. E., Klein W. L., Vaccination with soluble A oligomers generates toxicity-neutralizing antibodies Journal of Neurochemistry 2001 79 3 595 605 (Pubitemid 33029933)
38. Kamali-Moghaddam M., Pettersson F. E., Wu D., Englund H., Darmanis S., Lord A., Tavoosidana G., Sehlin D., Gustafsdottir S., Nilsson L. N. G., Lannfelt L., Landegren U., Sensitive detection of A protofibrils by proximity ligationrelevance for Alzheimer's disease BMC Neuroscience 2010 11, article 124
39. Schupf N., Tang M. X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R., Peripheral A subspecies as risk biomarkers of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 37 14052 14057
40. Klaver A. C., Patrias L. M., Finke J. M., Loeffler D. A., Specificity and sensitivity of the Abeta oligomer ELISA Journal of Neuroscience Methods 2011 195 2 249 254
41. Sehlin D., Sllvander S., Paulie S., Brundin R., Ingelsson M., Lannfelt L., Pettersson F. E., Englund H., Interference from heterophilic antibodies in amyloid- oligomer ELISAs Journal of Alzheimer's Disease 2010 21 4 1295 1301
42. Stenh C., Englund H., Lord A., Johansson A. S., Almeida C. G., Gellerfors P., Greengard P., Gouras G. K., Lannfelt L., Nilsson L. N. G., Amyloid- oligomers are inefficiently measured by enzyme-linked immunosorbent assay Annals of Neurology 2005 58 1 147 150 (Pubitemid 40962471)
43. Pitschke M., Prior R., Haupt M., Riesner D., Detection of single amyloid -protein aggregates in the cerebrospinal fluid of Alzheirner's patients by fluorescence correlation spectroscopy Nature Medicine 1998 4 7 832 834 (Pubitemid 28331026)
44. Henkel A. W., Dittrich P. S., Groemer T. W., Lemke E. A., Klingauf J., Klafki H. W., Lewczuk P., Esselmann H., Schwille P., Kornhuber J., Wiltfang J., Immune complexes of auto-antibodies against A 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients Molecular Psychiatry 2007 12 6 601 610 (Pubitemid 46816767)
45. Szabo P., Mujalli D. M., Rotondi M. L., Sharma R., Weber A., Schwarz H. P., Weksler M. E., Relkin N., Measurement of anti-beta amyloid antibodies in human blood Journal of Neuroimmunology 2010 227 1-2 167 174
46. Santos A. N., Torkler S., Nowak D., Schlittig C., Goerdes M., Lauber T., Trischmann L., Schaupp M., Penz M., Tiller F. W., Bhm G., Detection of amyloid- oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer Journal of Alzheimer's Disease 2007 11 1 117 125 (Pubitemid 46376713)
47. Santos A. N., Simm A., Holthoff V., Boehm G., A method for the detection of amyloid- 1-40, amyloid- 1-42 and amyloid- oligomers in blood using magnetic beads in combination with flow cytometry and its application in the diagnostics of Alzheimer's disease Journal of Alzheimer's Disease 2008 14 2 127 131 (Pubitemid 352040031)
48. Birkmann E., Henke F., Weinmann N., Dumpitak C., Groschup M., Funke A., Willbold D., Riesner D., Counting of single prion particles bound to a capture-antibody surface (surface-FIDA) Veterinary Microbiology 2007 123 4 294 304 (Pubitemid 47096766)
49. Funke S. A., Birkmann E., Henke F., Grtz P., Lange-Asschenfeldt C., Riesner D., Willbold D., Single particle detection of A aggregates associated with Alzheimer's disease Biochemical and Biophysical Research Communications 2007 364 4 902 907 (Pubitemid 350087886)
50. Funke S. A., Birkmann E., Henke F., Grtz P., Lange-Asschenfeldt C., Riesner D., Willbold D., An ultrasensitive assay for diagnosis of Alzheimer's disease Rejuvenation Research 2008 11 2 315 318 (Pubitemid 351601176)
51. Funke S. A., Wang L., Birkmann E., Willbold D., Single-particle detection system for a aggregates: adaptation of surface-fluorescence intensity distribution analysis to laser scanning microscopy Rejuvenation Research 2010 13 2-3 206 209
52. Englund H., Gunnarsson M. D., Brundin R. M., Hedlund M., Kilander L., Lannfelt L., Pettersson F. E., Oligomerization partially explains the lowering of A 42 in alzheimer's disease cerebrospinal fluid Neurodegenerative Diseases 2009 6 4 139 147
53. Andreasen N., Minthon L., Davidsson P., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K., Evaluation of CSF-tau and CSF-A 42 as diagnostic markers for Alzheimer disease in clinical practice Archives of Neurology 2001 58 3 373 379 (Pubitemid 32217453)
54. Kuo Y. M., Kokjohn T. A., Kalback W., Luehrs D., Galasko D. R., Chevallier N., Koo E. H., Emmerling M. R., Roher A. E., Amyloid- peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma Biochemical and Biophysical Research Communications 2000 268 3 750 756 (Pubitemid 30150863)
55. Xia W., Yang T., Shankar G., Smith I. M., Shen Y., Walsh D. M., Selkoe D. J., A specific enzyme-linked immunosorbent assay for measuring -amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer Disease Archives of Neurology 2009 66 2 190 199